Cargando…
p53 Stabilization Induces Cell Growth Inhibition and Affects IGF2 Pathway in Response to Radiotherapy in Adrenocortical Cancer Cells
Adrenocortical carcinoma (ACC) is a very rare endocrine tumour, with variable prognosis, depending on tumour stage and time of diagnosis. However, it is generally fatal, with an overall survival of 5 years from detection. Radiotherapy usefulness for ACC treatment has been widely debated and seems to...
Autores principales: | Sampaoli, Camilla, Cerquetti, Lidia, Gawhary, Randa El, Bucci, Barbara, Amendola, Donatella, Marchese, Rodolfo, Misiti, Silvia, Novelli, Giuseppe, Toscano, Vincenzo, Stigliano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446967/ https://www.ncbi.nlm.nih.gov/pubmed/23028800 http://dx.doi.org/10.1371/journal.pone.0045129 |
Ejemplares similares
-
Current and Emerging Therapeutic Options in Adrenocortical Cancer Treatment
por: Stigliano, Antonio, et al.
Publicado: (2012) -
Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer
por: Cerquetti, Lidia, et al.
Publicado: (2021) -
Antineoplastic Effect of a Combined Mitotane Treatment/Ionizing Radiation in Adrenocortical Carcinoma: A Preclinical Study
por: Cerquetti, Lidia, et al.
Publicado: (2019) -
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo
por: Chimento, Adele, et al.
Publicado: (2015) -
Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion
por: Amendola, Donatella, et al.
Publicado: (2014)